Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

September 30, 2025 updated by: San Diego State University

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and the subsequent benefit of improving type II diabetes outcomes in a low socioeconomic Hispanic population. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92182
        • Recruiting
        • San Diego State University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Mee Young Hong, PhD
        • Principal Investigator:
          • Robert J Castro, BS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Diagnosed with type II diabetes
  • Between the age of 18-64
  • BMI ≥ 27
  • Individual annual income less than $47,520 [Covered CA income guidelines and salary restrictions]
  • Hispanic and/or Latinx origin
  • Monitors blood glucose regularly
  • Owns or has access to a bathroom weight scale
  • Owns a smartphone and willing to download mobile apps

Exclusion Criteria:

  • Does not check blood glucose at least once per day
  • On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.

Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Weight Watchers (WW)
Intervention will be with two different mobile health (mHealth) applications, Weight Watchers and Healthi app (formerly iTrackBites)
Experimental: Healthi app
Intervention will be with two different mobile health (mHealth) applications, Weight Watchers and Healthi app (formerly iTrackBites)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of mHealth apps at reducing bodyweight assessed by bodyweight measurements over 6 months
Time Frame: 6 months
Determine if mHealth apps-Weight Watchers (WW) and Healthi app-are an effective weight loss modality compared to standard weight loss program (control)
6 months
Most effect intervention for weight loss in first 3 months
Time Frame: 6 months
Compare the three interventions, mHealth apps and control, against each other to determine which is most effective at achieving the maximum amount of weight loss within the first three months
6 months
Most effective intervention for weight loss by 6 months
Time Frame: 6 months
Compare and determine which intervention leads to the highest weight loss maintenance after six months
6 months
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire
Time Frame: 6 months
Compare and determine which intervention promotes self-efficacy in weight management
6 months
Long term diabetes improvement via A1c
Time Frame: 6 months
Compare and determine which intervention provides the best improvements towards diabetes via blood glucose and HbA1c
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire
Time Frame: 6 months
Comparing the three interventions to determine which leads to greater quality of life (QOL)
6 months
mhealthy app preference assessed by questionnaire
Time Frame: 6 months
Which mHealth app is more economically feasible for the participants and if feasibility changes after app usage. Outcome will be assessed with a questionnaire asking if the participant can afford the app.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

February 23, 2022

First Submitted That Met QC Criteria

March 6, 2022

First Posted (Actual)

March 15, 2022

Study Record Updates

Last Update Posted (Estimated)

October 6, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Mobile health application

Subscribe